Literature DB >> 22451605

Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication.

Xian Wu Cheng1, Guo-Ping Shi, Masafumi Kuzuya, Takeshi Sasaki, Kenji Okumura, Toyoaki Murohara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22451605     DOI： 10.1161/CIRCULATIONAHA.111.066712

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  53 in total

1.  Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients.

Authors:  Yusuke Izumi; Mutsuharu Hayashi; Ryota Morimoto; Xian Wu Cheng; Hongxian Wu; Hideki Ishii; Yoshinari Yasuda; Daiji Yoshikawa; Hideo Izawa; Seiichi Matsuo; Yutaka Oiso; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2014-08-24       Impact factor: 2.037

Review 2.  Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.

Authors:  Teemu J Niiranen; Ramachandran S Vasan
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-04-25

3.  Clinical significance of cathepsin L and cathepsin B in dilated cardiomyopathy.

Authors:  Siddharth Mehra; Manish Kumar; Mansi Manchanda; Ratnakar Singh; Bhaskar Thakur; Neha Rani; Sudheer Arava; Rajiv Narang; Dharamvir Singh Arya; Shyam S Chauhan
Journal:  Mol Cell Biochem       Date:  2017-01-10       Impact factor: 3.396

4.  Cathepsin Protease Inhibition Reduces Endometriosis Lesion Establishment.

Authors:  Kristi M Porter; Friedrich A Wieser; Catera L Wilder; Neil Sidell; Manu O Platt
Journal:  Reprod Sci       Date:  2015-10-19       Impact factor: 3.060

5.  Mast cell-deficiency protects mice from streptozotocin-induced diabetic cardiomyopathy.

Authors:  Aina He; Wenqian Fang; Kun Zhao; Yajun Wang; Jie Li; Chongzhe Yang; Feriel Benadjaoud; Guo-Ping Shi
Journal:  Transl Res       Date:  2019-01-19       Impact factor: 7.012

6.  Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology.

Authors:  Mark J Osborn; Beau R Webber; Ronald T McElmurry; Kyle D Rudser; Anthony P DeFeo; Michael Muradian; Anna Petryk; Benedikt Hallgrimsson; Bruce R Blazar; Jakub Tolar; Elizabeth A Braunlin
Journal:  J Inherit Metab Dis       Date:  2016-10-14       Impact factor: 4.982

7.  Increased plasma cathepsin S and trombospondin-1 in patients with acute ST-segment elevation myocardial infarction.

Authors:  Rahel Befekadu; Kjeld Christiansen; Anders Larsson; Magnus Grenegård
Journal:  Cardiol J       Date:  2018-04-03       Impact factor: 2.737

Review 8.  Mast cell chymase and tryptase in abdominal aortic aneurysm formation.

Authors:  Yi Wang; Guo-Ping Shi
Journal:  Trends Cardiovasc Med       Date:  2012-08-14       Impact factor: 6.677

9.  Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy.

Authors:  Yinan Hua; Xihui Xu; Guo-Ping Shi; Adam J Chicco; Jun Ren; Sreejayan Nair
Journal:  Hypertension       Date:  2013-03-25       Impact factor: 10.190

10.  IL-17A promotes ventricular remodeling after myocardial infarction.

Authors:  Su-Feng Zhou; Jing Yuan; Meng-Yang Liao; Ni Xia; Ting-Ting Tang; Jing-Jing Li; Jiao Jiao; Wen-Yong Dong; Shao-Fang Nie; Zheng-Feng Zhu; Wen-Cai Zhang; Bing-Jie Lv; Hong Xiao; Qing Wang; Xin Tu; Yu-Hua Liao; Guo-Ping Shi; Xiang Cheng
Journal:  J Mol Med (Berl)       Date:  2014-06-27       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.